Where does Crisi Medical Systems, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Crisi Medical Systems, Inc. ranks #7,130 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Crisi Medical Systems, Inc. hold?

Crisi Medical Systems, Inc. holds 46 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Crisi Medical Systems, Inc.'s Innovation Score?

Crisi Medical Systems, Inc. has an Innovation Score of 42.5 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Crisi Medical Systems, Inc.'s patent grant rate increasing or decreasing?

Crisi Medical Systems, Inc.'s recent grant velocity is -38% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Crisi Medical Systems, Inc.'s patents?

Crisi Medical Systems, Inc.'s patents average 22.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Crisi Medical Systems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Crisi Medical Systems, Inc.

Q: What technology areas does Crisi Medical Systems, Inc. focus on?

Crisi Medical Systems, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 39 patents, ranking #186 of 3,490 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 46 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Crisi ranks #7,130 of 49,997 tracked US assignees by granted-patent volume, with 46 patents across 11 technology areas.

#7,130
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.5/100): 22.3
avg claims per patent: -38%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7130 · US Corporation #7,130 · 46 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 46 grants
UPPER-Q #7,130/49,997
PHOTO-FINISH Calgary Scientific
CPC-FOCUS A61M · 11 areas
INNOV-PAR 42.5/100
CLAIMS-DENSE 22.3 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -38% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Calgary Scientific Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Crisi’s 42.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.3 pts (31%) Velocity 4.1 pts (10%) Breadth 11.7 pts (28%) Claim depth 13.4 pts (32%)

Qualcomm Incorporated · highest

85
Altair Engineering · near

42
Cambridge Silicon… · near

42
Crisi Medical Systems · this assignee

42
Occlutech · near

42
Patek Philippe Geneve · near

42
3D Lighting… · lowest

7

What this shows Crisi's Innovation Score is 42.5/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Crisi?

Each dot is one of Crisi’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Crisi’s own 22.3 claims/patent is ABOVE the 9.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Crisi vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Crisi's grants concentrate

Crisi Medical Systems, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 84.8% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (13 grants) versus a trough of 1 in 2016. By volume, Crisi sits between C.Uyemura & Co., Ltd. and China Institute of Water Resources and Hydropower Research.

Crisi's three-year grant acceleration

Crisi Medical Systems, Inc. shows 11 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

C Uyemura &

46
Canon Components

46
Changsha Universi…

46
CK Materials LAB

46
Cytec Technology

46
Calgary Scientific

46
Changzhou Raytech…

46
China Institute o…

46
Crisi Medical Sys… ◀

46

What this shows Crisi holds 46 patents at rank #7,127, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Crisi

By rank, the assignees closest to #7,127 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Crisi's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Crisi, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Crisi ranks #186 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Cambridge Silicon Radio Limited 42 Patek Philippe SA Geneve 42 Altair Engineering, Inc. 42 Occlutech GmbH 42

Crisi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Crisi Medical Systems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	8.7%
2016	1	2.2%
2017	2	4.3%
2018	6	13.0%
2019	13	28.3%
2020	4	8.7%
2021	1	2.2%
2022	5	10.9%
2023	6	13.0%
2025partial year	4	8.7%

Which technologies does Crisi Medical Systems, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 39

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 18

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 15

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 14

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 8

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 6

G06K - Graphical Data Reading ; Presentation OF DATA; Record CARRIERS; Handling Record Carriers 5

A61B - DIAGNOSIS; SURGERY; Identification 4

G05D - Systems FOR Controlling OR Regulating Non-electric Variables 3

G06F - Electric Digital Data Processing 2

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Crisi Medical Systems, Inc.'s patent record in context - here's where to go next.

Crisi Medical Systems, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 84.8% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #7,130 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Crisi Medical Systems, Inc. against C.Uyemura & Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.